30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Intellia Therapeutics Inc (NTLA)

Track

The most recent insider trading activity occurred on March 2, 2026, with two SELL transactions totaling $25,052. Prior to this, on January 5, 2026, there were multiple SELL and PLANNED_SALE transactions by executives, alongside a significant BUY transaction of $1,402,500 by Fred E. Cohen. The bulk of selling activity was concentrated in late 2025.
Stock chart
Ticker: NTLA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BASTA JAMES
EVP, General Counsel
1 sale — total 16,688 USD
Sale 2 Mar 2026
Value US$4,684,466.01 | Price 392.76 | Shares 81,499
Sale 2 Mar 2026
Value US$1,840,372.67 | Price 462.73 | Shares 6,346
Sale 5 Jan 2026
Value US$314,484.66 | Price 9.21 | Shares 34,146
Planned sale 5 Jan 2026
Value US$78,358.68 | Price 9.21 | Shares 8,508
Sale 5 Jan 2026
Value US$58,750.59 | Price 9.21 | Shares 6,379
Planned sale 5 Jan 2026
Value US$87,633.15 | Price 9.21 | Shares 9,515
Buy 5 Jan 2026
Value US$1,402,500.00 | Price 9.35 | Shares 150,000
Sale 5 Jan 2026
Value US$95,756.37 | Price 9.21 | Shares 10,397
Planned sale 5 Jan 2026
Value US$109,626.63 | Price 9.21 | Shares 11,903
Sale 5 Jan 2026
Value US$27,528.69 | Price 9.21 | Shares 2,989
Planned sale 11 Dec 2025
Value US$51,354.45 | Price 9.59 | Shares 5,355
Planned sale 11 Dec 2025
Value US$310,919.04 | Price 9.47 | Shares 32,832
Planned sale 11 Dec 2025
Value US$474,110.91 | Price 9.49 | Shares 49,959
Proposed sale 11 Dec 2025
Value US$822,402.00 | Price 9.33 | Shares 88,146
Sale 1 Oct 2025
Value US$32,517.98 | Price 17.38 | Shares 1,871
Sale 1 Oct 2025
Value US$538.78 | Price 17.38 | Shares 31
Buy 20 Aug 2025
Value US$1,003,000.00 | Price 10.03 | Shares 100,000
Sale 23 Jul 2025
Value US$104,617.24 | Price 14.02 | Shares 7,462
Sale 2 Jul 2025
Value US$24,904.85 | Price 9.95 | Shares 2,503
Planned sale 1 Jul 2025
Value US$10,036.04 | Price 9.82 | Shares 1,022
Planned sale 1 Jul 2025
Value US$14,278.81 | Price 9.23 | Shares 1,547
Planned sale 30 Jun 2025
Value US$14,789.32 | Price 9.56 | Shares 1,547
Planned sale 29 Apr 2025
Value US$2,252.50 | Price 8.50 | Shares 265
Sale 4 Mar 2025
Value US$6,104.21 | Price 8.99 | Shares 679
Sale 4 Mar 2025
Value US$23,122.28 | Price 8.99 | Shares 2,572
Planned sale 29 Jan 2025
Value US$2,642.05 | Price 9.97 | Shares 265
Sale 3 Jan 2025
Value US$16,710.96 | Price 12.18 | Shares 1,372
Sale 3 Jan 2025
Value US$79,194.36 | Price 12.18 | Shares 6,502
Sale 3 Jan 2025
Value US$326,509.26 | Price 12.18 | Shares 26,807
Sale 3 Jan 2025
Value US$86,161.32 | Price 12.18 | Shares 7,074
Sale 3 Jan 2025
Value US$116,404.26 | Price 12.18 | Shares 9,557
Sale 3 Jan 2025
Value US$109,205.88 | Price 12.18 | Shares 8,966
Sale 3 Jan 2025
Value US$90,399.96 | Price 12.18 | Shares 7,422
Planned sale 2 Jan 2025
Value US$6,688.68 | Price 12.03 | Shares 556
Sale 2 Oct 2024
Value US$38,248.12 | Price 19.01 | Shares 2,012
Planned sale 1 Jul 2024
Value US$9,286.65 | Price 22.93 | Shares 405
Planned sale 17 Jun 2024
Value US$37,625.00 | Price 25.00 | Shares 1,505
Sale 4 Mar 2024
Value US$75,778.03 | Price 32.99 | Shares 2,297
Sale 4 Mar 2024
Value US$19,958.95 | Price 32.99 | Shares 605
Planned sale 8 Jan 2024
Value US$19,596.46 | Price 29.38 | Shares 667
Planned sale 8 Jan 2024
Value US$46,085.28 | Price 28.66 | Shares 1,608
Proposed sale 8 Jan 2024
Value US$64,109.00 | Price 28.18 | Shares 2,275
Sale 3 Jan 2024
Value US$158,052.90 | Price 29.46 | Shares 5,365
Sale 3 Jan 2024
Value US$114,216.42 | Price 29.46 | Shares 3,877
Sale 3 Jan 2024
Value US$162,972.72 | Price 29.46 | Shares 5,532
Sale 3 Jan 2024
Value US$566,309.58 | Price 29.46 | Shares 19,223
Sale 3 Jan 2024
Value US$126,707.46 | Price 29.46 | Shares 4,301
Planned sale 3 Jan 2024
Value US$9,246.84 | Price 30.12 | Shares 307
Sale 3 Jan 2024
Value US$172,134.78 | Price 29.46 | Shares 5,843
Sale 3 Jan 2024
Value US$112,095.30 | Price 29.46 | Shares 3,805
Proposed sale 6 Dec 2023
Value US$506,703.83 | Price 15.45 | Shares 32,791
Planned sale 31 Oct 2023
Value US$6,333.50 | Price 23.90 | Shares 265
Planned sale 31 Jul 2023
Value US$11,217.45 | Price 42.33 | Shares 265
Proposed sale 31 Jul 2023
Value US$11,217.45 | Price 42.33 | Shares 265
Planned sale 6 Jul 2023
Value US$73,373.10 | Price 39.30 | Shares 1,867
Proposed sale 6 Jul 2023
Value US$73,377.77 | Price 39.30 | Shares 1,867
Planned sale 3 Jul 2023
Value US$14,583.60 | Price 40.51 | Shares 360
Planned sale 20 Jun 2023
Value US$225,000.00 | Price 45.00 | Shares 5,000
Proposed sale 20 Jun 2023
Value US$225,000.00 | Price 45.00 | Shares 5,000
Sale 2 Mar 2023
Value US$47,741.44 | Price 43.88 | Shares 1,088
Planned sale 5 Jan 2023
Value US$26,939.90 | Price 39.10 | Shares 689
Planned sale 5 Jan 2023
Value US$62,719.02 | Price 38.22 | Shares 1,641
Sale 4 Jan 2023
Value US$67,424.52 | Price 37.21 | Shares 1,812
Sale 4 Jan 2023
Value US$95,778.54 | Price 37.21 | Shares 2,574
Sale 4 Jan 2023
Value US$42,344.98 | Price 37.21 | Shares 1,138
Sale 4 Jan 2023
Value US$248,302.33 | Price 37.21 | Shares 6,673
Sale 4 Jan 2023
Value US$93,322.68 | Price 37.21 | Shares 2,508
Sale 4 Jan 2023
Value US$62,959.32 | Price 37.21 | Shares 1,692
Sale 4 Jan 2023
Value US$90,308.67 | Price 37.21 | Shares 2,427
Planned sale 3 Jan 2023
Value US$7,964.88 | Price 34.48 | Shares 231
Planned sale 1 Jul 2022
Value US$5,432.70 | Price 51.74 | Shares 105
Sale 1 Jan 2022
Value US$279,851.72 | Price 112.26 | Shares 2,493
Sale 1 Jan 2022
Value US$128,863.00 | Price 112.25 | Shares 1,148
Sale 1 Jan 2022
Value US$117,964.24 | Price 112.24 | Shares 1,051
Sale 1 Jan 2022
Value US$113,699.12 | Price 112.24 | Shares 1,013
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-03 2026-03-02 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
81,499 -12.1%
392.76
US$4,684,466 		81,499 -12.1% 392.76 US$4,684,466
2026-03-03 2026-03-02 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
6,346 +11.2%
462.73
US$1,840,373 		6,346 +11.2% 462.73 US$1,840,373
2026-01-07 2026-01-05 S Sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
93,688 -15.7%
116.58
US$1,395,612 		93,688 -15.7% 116.58 US$1,395,612
2026-01-07 2026-01-05 PlS Planned sale
3.2
Schultes Birgit C

EVP, Chief Scientific Officer

Officer
8,508 -7.9%
9.21
US$78,359 		8,508 -7.9% 9.21 US$78,359
2026-01-07 2026-01-05 S Sale
4.0
Dulac Edward J III

EVP, Chief Financial Officer

Officer
6,379 -6.0%
9.21
US$58,751 		6,379 -6.0% 9.21 US$58,751
2026-01-07 2026-01-05 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
9,515 -9.8%
9.21
US$87,633 		9,515 -9.8% 9.21 US$87,633
2026-01-07 2026-01-05 B Purchase
3.3
Cohen Fred E
Non-Executive Director
150,000 +261.1%
9.35
US$1,402,500 		150,000 +261.1% 9.35 US$1,402,500
2026-01-07 2026-01-05 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
10,397 -9.3%
9.21
US$95,756 		10,397 -9.3% 9.21 US$95,756
2026-01-07 2026-01-05 PlS Planned sale
3.9
Lebwohl David

EVP, Chief Medical Officer

Officer
11,903 -8.9%
9.21
US$109,627 		11,903 -8.9% 9.21 US$109,627
2026-01-07 2026-01-05 S Sale
3.4
Dube Michael P

VP, Chief Accounting Officer

Officer
2,989 -5.4%
9.21
US$27,529 		2,989 -5.4% 9.21 US$27,529
2025-12-12 2025-12-11 PlS Planned sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
5,355 -0.5%
9.59
US$51,354 		5,355 -0.5% 9.59 US$51,354
2025-12-12 2025-12-11 PlS Planned sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
32,832 -3.0%
9.47
US$310,919 		32,832 -3.0% 9.47 US$310,919
2025-12-12 2025-12-11 PlS Planned sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
49,959 -4.4%
9.49
US$474,111 		49,959 -4.4% 9.49 US$474,111
2025-12-11 2025-12-11 PrS Proposed sale
2.4
LEONARD JOHN M

Officer; Director

Executive Director
88,146
9.33
US$822,402 		88,146 9.33 US$822,402
2025-10-03 2025-10-01 S Sale
3.4
Dube Michael P

VP, Chief Accounting Officer

Officer
1,871 -3.3%
17.38
US$32,518 		1,871 -3.3% 17.38 US$32,518
2025-10-03 2025-10-01 S Sale
3.2
Schultes Birgit C

EVP, Chief Scientific Officer

Officer
31 -0.0%
17.38
US$539 		31 -0.0% 17.38 US$539
2025-08-22 2025-08-20 B Purchase
3.2
CHASE WILLIAM J
Non-Executive Director
100,000 +288.2%
10.03
US$1,003,000 		100,000 +288.2% 10.03 US$1,003,000
2025-07-25 2025-07-23 S Sale
4.0
Dulac Edward J III

EVP, Chief Financial Officer

Officer
7,462 -6.6%
14.02
US$104,617 		7,462 -6.6% 14.02 US$104,617
2025-07-03 2025-07-02 S Sale
3.4
Dube Michael P

VP, Chief Accounting Officer

Officer
2,503 -4.2%
9.95
US$24,905 		2,503 -4.2% 9.95 US$24,905
2025-07-03 2025-07-01 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
1,022 -1.1%
9.82
US$10,036 		1,022 -1.1% 9.82 US$10,036
2025-07-02 2025-07-01 PlS Planned sale
GOODMAN JESSE
Non-Executive Director
1,547 -6.0%
9.23
US$14,279 		1,547 -6.0% 9.23 US$14,279
2025-07-02 2025-06-30 PlS Planned sale
GOODMAN JESSE
Non-Executive Director
1,547 -5.6%
9.56
US$14,789 		1,547 -5.6% 9.56 US$14,789
2025-05-01 2025-04-29 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
265 -1.4%
8.50
US$2,252 		265 -1.4% 8.50 US$2,252
2025-03-04 2025-03-04 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
679 -0.7%
8.99
US$6,104 		679 -0.7% 8.99 US$6,104
2025-03-04 2025-03-04 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
2,572 -2.2%
8.99
US$23,122 		2,572 -2.2% 8.99 US$23,122
2025-01-31 2025-01-29 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
265 -1.3%
9.97
US$2,642 		265 -1.3% 9.97 US$2,642
2025-01-07 2025-01-03 S Sale
3.4
Dube Michael P

VP, Chief Accounting Officer

Officer
1,372 -2.9%
12.18
US$16,711 		1,372 -2.9% 12.18 US$16,711
2025-01-07 2025-01-03 S Sale
3.6
Hicks Derek

EVP, Chief Business Officer

Officer
6,502 -9.8%
12.18
US$79,194 		6,502 -9.8% 12.18 US$79,194
2025-01-07 2025-01-03 S Sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
26,807 -2.8%
12.18
US$326,509 		26,807 -2.8% 12.18 US$326,509
2025-01-07 2025-01-03 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
7,074 -8.7%
12.18
US$86,161 		7,074 -8.7% 12.18 US$86,161
2025-01-07 2025-01-03 S Sale
3.9
Lebwohl David

EVP, Chief Medical Officer

Officer
9,557 -9.8%
12.18
US$116,404 		9,557 -9.8% 12.18 US$116,404
2025-01-07 2025-01-03 S Sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
8,966 -10.4%
12.18
US$109,206 		8,966 -10.4% 12.18 US$109,206
2025-01-06 2025-01-03 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
7,422 -10.4%
12.18
US$90,400 		7,422 -10.4% 12.18 US$90,400
2025-01-06 2025-01-02 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
556 -0.8%
12.03
US$6,689 		556 -0.8% 12.03 US$6,689
2024-10-04 2024-10-02 S Sale
3.4
Dube Michael P

VP, Chief Accounting Officer

Officer
2,012 -4.1%
19.01
US$38,248 		2,012 -4.1% 19.01 US$38,248
2024-07-03 2024-07-01 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
405 -0.6%
22.93
US$9,287 		405 -0.6% 22.93 US$9,287
2024-06-20 2024-06-17 PlS Planned sale
Verwiel Frank
Non-Executive Director
1,505 -7.7%
25.00
US$37,625 		1,505 -7.7% 25.00 US$37,625
2024-03-05 2024-03-04 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
2,297 -2.7%
32.99
US$75,778 		2,297 -2.7% 32.99 US$75,778
2024-03-05 2024-03-04 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
605 -0.8%
32.99
US$19,959 		605 -0.8% 32.99 US$19,959
2024-01-10 2024-01-08 PlS Planned sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
667 -1.5%
29.38
US$19,596 		667 -1.5% 29.38 US$19,596
2024-01-10 2024-01-08 PlS Planned sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
1,608 -3.5%
28.66
US$46,085 		1,608 -3.5% 28.66 US$46,085
2024-01-08 2024-01-08 PrS Proposed sale
3.9
Sepp-Lorenzino Laura

Officer

Officer
2,275
28.18
US$64,109 		2,275 28.18 US$64,109
2024-01-05 2024-01-03 S Sale
3.6
Goddard Glenn

EVP, Chief Financial Officer

Officer
5,365 -11.7%
29.46
US$158,053 		5,365 -11.7% 29.46 US$158,053
2024-01-05 2024-01-03 S Sale
3.6
Hicks Derek

EVP, Chief Business Officer

Officer
3,877 -9.5%
29.46
US$114,216 		3,877 -9.5% 29.46 US$114,216
2024-01-05 2024-01-03 S Sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
5,532 -10.7%
29.46
US$162,973 		5,532 -10.7% 29.46 US$162,973
2024-01-05 2024-01-03 S Sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
19,223 -2.2%
29.46
US$566,310 		19,223 -2.2% 29.46 US$566,310
2024-01-05 2024-01-03 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
4,301 -9.5%
29.46
US$126,707 		4,301 -9.5% 29.46 US$126,707
2024-01-05 2024-01-03 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
307 -0.7%
30.12
US$9,247 		307 -0.7% 30.12 US$9,247
2024-01-05 2024-01-03 S Sale
3.9
Lebwohl David

EVP, Chief Medical Officer

Officer
5,843 -9.7%
29.46
US$172,135 		5,843 -9.7% 29.46 US$172,135
2024-01-05 2024-01-03 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
3,805 -6.9%
29.46
US$112,095 		3,805 -6.9% 29.46 US$112,095
2023-12-07 2023-12-06 PrS Proposed sale
3.6
John F. Crowley

Former Director

Non-Executive Director
32,791
15.45
US$506,704 		32,791 15.45 US$506,704
2023-11-02 2023-10-31 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
265 -2.2%
23.90
US$6,334 		265 -2.2% 23.90 US$6,334
2023-08-02 2023-07-31 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
265 -2.1%
42.33
US$11,217 		265 -2.1% 42.33 US$11,217
2023-07-31 2023-07-31 PrS Proposed sale
2.0
MUNA BHANJI

Director

Non-Executive Director
265
42.33
US$11,217 		265 42.33 US$11,217
2023-07-10 2023-07-06 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
1,867 -13.0%
39.30
US$73,373 		1,867 -13.0% 39.30 US$73,373
2023-07-06 2023-07-06 PrS Proposed sale
2.0
MUNA BHANJI

Director

Non-Executive Director
1,867
39.30
US$73,378 		1,867 39.30 US$73,378
2023-07-06 2023-07-03 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
360 -0.8%
40.51
US$14,584 		360 -0.8% 40.51 US$14,584
2023-06-22 2023-06-20 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
5,000 -10.0%
45.00
US$225,000 		5,000 -10.0% 45.00 US$225,000
2023-06-20 2023-06-20 PrS Proposed sale
4.0
ELIANA CLARK

Officer

Officer
5,000
45.00
US$225,000 		5,000 45.00 US$225,000
2023-03-03 2023-03-02 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
1,088 -1.9%
43.88
US$47,741 		1,088 -1.9% 43.88 US$47,741
2023-01-06 2023-01-05 PlS Planned sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
689 -3.8%
39.10
US$26,940 		689 -3.8% 39.10 US$26,940
2023-01-06 2023-01-05 PlS Planned sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
1,641 -8.2%
38.22
US$62,719 		1,641 -8.2% 38.22 US$62,719
2023-01-06 2023-01-04 S Sale
3.6
Hicks Derek

EVP, Chief Business Officer

Officer
1,812 -9.5%
37.21
US$67,425 		1,812 -9.5% 37.21 US$67,425
2023-01-06 2023-01-04 S Sale
3.9
Lebwohl David

EVP, Chief Medical Officer

Officer
2,574 -9.1%
37.21
US$95,779 		2,574 -9.1% 37.21 US$95,779
2023-01-06 2023-01-04 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
1,138 -5.5%
37.21
US$42,345 		1,138 -5.5% 37.21 US$42,345
2023-01-06 2023-01-04 S Sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
6,673 -0.9%
37.21
US$248,302 		6,673 -0.9% 37.21 US$248,302
2023-01-06 2023-01-04 S Sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
2,508 -11.2%
37.21
US$93,323 		2,508 -11.2% 37.21 US$93,323
2023-01-06 2023-01-04 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
1,692 -10.5%
37.21
US$62,959 		1,692 -10.5% 37.21 US$62,959
2023-01-06 2023-01-04 S Sale
3.6
Goddard Glenn

EVP, Chief Financial Officer

Officer
2,427 -13.6%
37.21
US$90,309 		2,427 -13.6% 37.21 US$90,309
2023-01-06 2023-01-03 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
231 -1.4%
34.48
US$7,965 		231 -1.4% 34.48 US$7,965
2023-01-06 2022-07-01 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
105 -0.6%
51.74
US$5,433 		105 -0.6% 51.74 US$5,433
2022-03-04 2022-01-01 S Sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
2,493 -0.3%
112.26
US$279,852 		2,493 -0.3% 112.26 US$279,852
2022-03-03 2022-01-01 S Sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
1,148 -19.3%
112.25
US$128,863 		1,148 -19.3% 112.25 US$128,863
2022-03-03 2022-01-01 S Sale
3.9
Lebwohl David

EVP, Chief Medical Officer

Officer
1,051 -8.8%
112.24
US$117,964 		1,051 -8.8% 112.24 US$117,964
2022-03-03 2022-01-01 S Sale
3.6
Goddard Glenn

EVP, Chief Financial Officer

Officer
1,013 -33.1%
112.24
US$113,699 		1,013 -33.1% 112.24 US$113,699
Explore more

More insider trading research around Intellia Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America